TRAVERSA SERGIO

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$967,657.29
Insider Sells Quantity
14
Insider Sells Sum
$1.8M

Insider Activity of TRAVERSA SERGIO

According to the SEC Form 4 filings, TRAVERSA SERGIO, being in a position of

  1. Chief Executive Officer at Relmada Therapeutics, Inc.,
    оver the last 12 months, has bought 240000 shares for $781,852, and sold 0 shares,
    over all time since 2015-12-14, has bought 314250 shares for $955,537, and sold 54068 shares for $1.8M.

The largest purchase of all time was on 2024-01-30 and amounted to 40999 shares of Relmada Therapeutics, Inc. for $159,949.

The largest sale of all time was on 2021-02-24 and amounted to 10000 shares of Relmada Therapeutics, Inc. for $342,392.

Biography of TRAVERSA SERGIO

No biography is available at this moment.

2024-09-11PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
51,407
0.1813%
$2.99$153,707+9.36%
2024-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
33,014
0.1071%
$2.75$90,789+16.73%
2024-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
55,579
0.1789%
$2.71$150,619+17.38%
2024-01-31PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
27,460
0.0923%
$4.00$109,752-11.2%
2024-01-30PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
40,999
0.1345%
$3.90$159,949-10.97%
2024-01-29PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
31,541
0.1037%
$3.71$117,036-7.18%
2022-12-08PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
55,250
0.1801%
$2.10$115,804+37.79%
2022-06-30SaleRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
4,068
0.0131%
$18.32$74,526-78.46%
2021-03-10SaleRelmada Therapeutics, Inc.
RLMD
CEO
2,983
0.0181%
$35.09$104,676-27.16%
2021-03-09SaleRelmada Therapeutics, Inc.
RLMD
CEO
7,017
0.0434%
$35.65$250,169-27.03%
2021-02-24SaleRelmada Therapeutics, Inc.
RLMD
CEO
10,000
0.0601%
$34.24$342,392-24.9%
2021-02-11SaleRelmada Therapeutics, Inc.
RLMD
CEO
1,446
0.0086%
$35.43$51,238-27.26%
2021-02-10SaleRelmada Therapeutics, Inc.
RLMD
CEO
1,930
0.0118%
$35.28$68,097-24.81%
2021-02-09SaleRelmada Therapeutics, Inc.
RLMD
CEO
5,963
0.0362%
$35.21$209,939-24.84%
2021-02-08SaleRelmada Therapeutics, Inc.
RLMD
CEO
3,313
0.02%
$35.03$116,049-24.46%
2021-02-03SaleRelmada Therapeutics, Inc.
RLMD
CEO
100
0.0006%
$35.00$3,500-22.43%
2021-02-02SaleRelmada Therapeutics, Inc.
RLMD
CEO
3,178
0.0192%
$35.08$111,470-23.54%
2021-01-27SaleRelmada Therapeutics, Inc.
RLMD
CEO
10,000
0.062%
$32.39$323,914-13.04%
2021-01-26SaleRelmada Therapeutics, Inc.
RLMD
CEO
600
0.0037%
$35.15$21,090-20.02%
2021-01-25SaleRelmada Therapeutics, Inc.
RLMD
CEO
1,300
0.0078%
$35.29$45,877-19.32%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.